To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Suprascapular Nerve Blocks for Subacute Adhesive Capsulitis

Download
Share
Reprints
Cite This
About
+ Favorites
Download
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
September 2022

Suprascapular Nerve Blocks for Subacute Adhesive Capsulitis

Vol: 297| Issue: 1| Number:1| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Randomized controlled trial of suprascapular nerve blocks for subacute adhesive capsulitis

Eur J Phys Rehabil Med . 2022 Aug;58(4):630-637.

Contributing Authors:
M Schiltz N Beeckmans B Gillard T DE Baere SM Hatem

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Thirty-five patients with subacute adhesive capsulitis were randomized to receive either a suprascapular nerve block with ropivacaine (n=19) or saline (n=16). The primary outcome of this trial was shoulder function using the Constant-Murley Score after 4 weeks. Secondary outcomes assessed range of motion and shoulder pain intensity 4 weeks after the last injection. No significant differences were ...

Join the Conversation

Please Login or Join to leave comments.